Sollis Therapeutics' Series A Round

Sollis Therapeutics raised a round of funding on April 12, 2018. Investors include Deerfield Management.

Sollis Therapeutics is a clinical-stage biotechnology company focused on developing novel non-steroid, non-opioid analgesics. The company's first product is an extended release combination analgesic a…

Articles about Sollis Therapeutics' Series A Round: